Publicaties
2023
Wetenschappelijke publicaties
Trials@Home Consortium (2023). Opportunities and challenges for decentralized clinical trial approaches: European health technology assessment perspective. Value in Health. Advance online publication. https://doi.org/10.1016/j.jval.2023.11.006
Trials@Home Consortium (2023). Direct-to-Participant Investigational Medicinal Product Supply in Clinical Trials in Europe - Exploring the Experiences of Sponsors, Site Staff, and Couriers. British Journal of Clinical Pharmacology, 89(12), 3512-3522. https://doi.org/10.1111/bcp.15850
Trials@Home Consortium (2023). Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus. Drug Discovery Today, 28(4), Article 103520. https://doi.org/10.1016/j.drudis.2023.103520
2022
Wetenschappelijke publicaties
Trials@Home Consortium (2022). Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review. Drug Discovery Today, 27(10), 1-6. Article 103326. https://doi.org/10.1016/j.drudis.2022.07.011
Trials@Home Consortium (2022). Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019-2020? A cross-sectional study in ClinicalTrials.gov. BMJ Open, 12(8). https://doi.org/10.1136/bmjopen-2022-063236
Trials@Home Consortium (2022). Opportunities and Challenges for Decentralized Clinical Trials: European Regulators' Perspective. Clinical Pharmacology and Therapeutics, 112(2), 344-352. https://doi.org/10.1002/cpt.2628
2021
Wetenschappelijke publicaties
Trials@Home Consortium (2021). COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union. Clinical Pharmacology and Therapeutics, 109(6), 1517-1527. https://doi.org/10.1002/cpt.2225